Accuracy of tele-consultation on management decisions of lesions suspect for melanoma using reflectance confocal microscopy as a stand-alone diagnostic tool
- A. Scope,
- S. W. Dusza,
- G. Pellacani,
- M. Gill,
- S. Gonzalez,
- M. A. Marchetti
- Tel Aviv University,
- Memorial Sloan-Kettering Cancer Center,
- University of Modena and Reggio Emilia,
- SUNY Downstate Health Sciences University,
- Skin Medical Research and Diagnostics,
- University of Alcalá
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Background: Diagnostic accuracy of reflectance confocal microscopy (RCM) as a stand-alone diagnostic tool for suspect skin lesions has not been extensively studied. Objective: Primary aim was to measure experts’ accuracy in RCM-based management decisions. Secondary aim was to identify melanoma-specific RCM features. Methods: The study enrolled patients ≥18 years that underwent biopsy of skin lesions clinically suspected to be melanoma. One hundred lesions imaged by RCM were randomly selected from 439 lesions prospectively collected at four pigmented lesion clinics. The study data set included 23 melanomas, three basal cell and two squamous cell carcinomas, 11 indeterminate melanocytic lesions and 61 benign lesions including 50 nevi. Three expert RCM evaluators were blinded to clinical or dermoscopic images, and to the final histopathological diagnosis. Evaluators independently issued a binary RCM-based management decision, ‘biopsy’ vs. ‘observation’; these decisions were scored against histopathological diagnosis, with ‘biopsy’ as the correct management decision for malignant and indeterminate lesions. A subset analysis of 23 melanomas and 50 nevi with unequivocal histopathological diagnosis was performed to identify melanoma-specific RCM features. Results: Sensitivity, specificity and diagnostic accuracy were 74%, 67% and 70% for reader 1, 46%, 84% and 69% for reader 2, and 72%, 46% and 56% for reader 3, respectively. The overall kappa for management decisions was 0.34. Readers had unanimous agreement on management for 50 of the 100 lesions. Non-specific architecture, non-visible papillae, streaming of nuclei, coarse collagen fibres and abnormal vasculature showed a significant association with melanoma in the evaluation of at least two readers. Conclusions: Reflectance confocal microscopy tele-consultation of especially challenging lesions, based on image review without benefit of clinical or dermoscopy images, may be associated with limited diagnostic accuracy and interobserver agreement. Architectural and stromal criteria may emerge as potentially useful and reproducible criteria for melanoma diagnosis.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 439-446 (8 pages)Journal (Volume, Issue Number)
Journal of the European Academy of Dermatology and Venereology (Volume 33, Issue 2)Publication milestones
- Published - 02/2019
Publication status
Published - 02/2019
ISSN
0926-9959Publication IDs
- Scopus: 85056078498
- PubMed: 30242916
Publication metrics
Metrics
Fractional count
1
Fractional count
0.10
Fractional count
9
Fractional count
0.90
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Social media
8
Citation count
12
Captures
71
Funding Details
This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 and by the NIH/NCI Grant 5R44CA058054-06. Funding source was not involved in design and conduct of the study, collection, management, analysis and interpretation of data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication.
Dr. Pellacani – honoraria for courses on confocal microscopy from MAVIG GmbH and advisory board member for Caliber ID, manufacturer of a confocal microscope. Dr. Gill was a funded investigator of the NCI grant. She has no relevant conflicts of interest to report. Dr. Gonzalez – scientific Advisory Board member of Caliber ID. Dr. Rabinovitz – speaker and clinical investigator for Caliber ID. Ms. Alessi-Fox – employee and a shareholder of CaliberID. Dr. Halpern – scientific Advisory Board member of Caliber ID. Disclosure for all the other authors – None reported.
Funding sources This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 and by the NIH/NCI Grant 5R44CA058054-06. Funding source was not involved in design and conduct of the study, collection, management, analysis and interpretation of data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication. The authors thank Alice Pentland, MD (Chair and Professor of Dermatology, University of Rochester Medical Center, New York, NY) and Abel Torres, MD, JD (Chair and Professor of Dermatology, Loma Linda University Medical Center, Loma Linda, CA) for their contribution in patient accrual and acquisition of study data.
FundersFunding numbers
Center for Pediatric Prehospital Care Loma Linda University Medical Center Loma Linda
-NCI, NIH
-NIH
-NCI
P30CA008748, 5R44CA058054-06
URMC
-